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June Supplement 201030S Abstractswhether they were on statins or not. In patients with
suprarenal fixation not receiving statins, a deterioration in
renal function was observed in the early postoperative
period (SCr preop vs SCr Postop.: 1.02  0.2 vs 1.11 
0.28, p  .001 and Cr. Cl preop vs Cr. Cl postop.: 74.1 
21.4 vs 68.0 21.4, p .001), whereas patients on statins
experienced no change in renal function (SCr preop vs SCr
postop: 0.99  0.24 vs 1.02  0.20 n.s. and Cr. Cl preop
vs Cr. Clpostop.: 76.4  19.1 vs 74.28  20.50, n.s.).
During follow-up, a constant worsening of renal function
at six and twelve months in all patients was observed,
irrespective of the medication with statins.
Conclusions: The present study suggests a slight
immediate deterioration of the renal function using SR
fixation, and this could be prevented by the use of statins.
During follow-up, statins did not protect from further
renal deterioration. Broader studies are needed to con-
firm a definitive relation between statin use and renal
protection during the endovascular repair of AAA.
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Objectives: To determine if EVAR improves outcomes
for ruptured AAA (rAAA). EVAR has become first line
therapy for rAAA at our institution, after initiating a pro-
tocol to efficiently evaluate aneurysm anatomy and facilitate
operating room access. This includes dedicated on-call staff
and a fully stocked endosuite.
Methods: Charts were retrospectively reviewed from
December 2000 to November 2009 for repair of infrarenal
rAAA. Primary endpoints include in-hospital mortality and
long-term survival. Secondary endpoints, include acute
limb ischemia, length of stay (LOS), ventilator dependent
respiratory failure (VDRF) and renal failure. Statistics in-
clude t-test, chi-square, Kaplan Meier, and multivariate
logistic regression.
Results: Fifty-four patients underwent repair (15
EVAR, 45 Open). In-hospital mortality was 20% EVAR
and 51% open (p  0.01, odds ratio [OR] 8.6, 95%
confidence interval [CI], 1.7-42.8). Kaplan Meier analysis
shows improved long-term survival with EVAR (p  0.05,
log rank). Mean LOS ( 1 day) was 9.1 days for EVAR and
21.5 days for open repair (p  0.05). VDRF was 7% for
EVAR and 38% for open repair (p 0.05, OR 8.6 [95% CI
1.02-72.4]). EVAR utilization increased from 17% to 60%
over the study period.Conclusions:Endovascular repair of rAAA used within
a protocol to facilitate anatomic evaluation and operating
room access reduced both in-hospital mortality and long-
termmortality significantly, as well as perioperative compli-
cations and LOS.
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Objectives: To evaluate the short- and long-term out-
come of Fascial Closure Technique (FC) as a means of
closure of femoral artery access sites after EVAR.
Methods: 92 consecutive patients (163 femoral access
sites) between April 2007 and April 2008 were evaluated
retrospectively. 33 procedures (36%)were emergent. Pre- and
postoperative data were collected from computerizedmedical
records for analysis of demographics and the rate of compli-
cations (bleeding, infection, thrombosis, pseudoaneurysms,
stenosis). Pre- and one year postoperative CT measurements
were performed with regards to stenosis, presence of plaque,
subcutaneous fat layer, thrombosis and pseudoaneurysms.
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by FS as first choice, traditional cut-down was primarily
performed in 11.4% and percutaneus closure device was
used in 0.6%. 9% of the FS closed access sites were con-
verted to open cut-down closure intraoperatively because
of bleeding (7%) or stenosis (2%). Data from the one year
follow-up show no signs of increased stenosis, thrombosis
or formation of plaque. 4 pseudoaneurysms (3%) were
detected and 2 of these warranted surgical repair.
Conclusions: FS is technically feasible, economically
sound and appears to be a safe and effective method of
closure of femoral access sites after EVAR.Most short-term
complications are easily detected and managed intraopera-
tively. Few long-term complications were detected.
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Objectives: The Endurant (Medtronic) is a new stent-
graft designed to reduce complications while widening the
applicability of EVAR. This study presents the 1-year re-
sults of the Endurant in “real-life practise.”
Methods: All clinical pre-, per- and postoperative data
of Endurant patients of our 3 centers is prospectively col-
lected. Patients undergo CTAs preoperatively, and 1
month and yearly post-EVAR. All patients with completed
1-year follow-up were included. Clinical data, AAA charac-
teristics, presence of endoleaks (EL), graft migration (5
mm), and other EVAR related complications were noted.
All values are stated as mean (range).
Results: 66 AAA patients were included {61 male,
AAA size 63 mm (45-89), AAA volume 202 mL (68-548),
neck length 32 mm (9-70), angulation 39° (0-109)}. Pri-
mary technical success was achieved in 98.5% (1 stent
placed in renal artery) with no primary type I/III ELs or
conversions. Thirty-day mortality was 0%. On the first
postoperative CTA, 10 ELs were seen (15%, all type II).
One-year follow-up showed four iliac limb occlusions (6%,
all due to poor outflow), and 1 infected stentgraft (causing
a type I EL). Five endovascular reinterventions were per-
formed (8%; 4 to treat iliac limb occlusions, 1 proximal
extension cuff). 1-year mortality was 13.7% (9 patients).
AAA-related mortality was 1.5% (the 1 with stentgraft
infection). The mean AAA size had decreased significantly
after 1 year {diameter: 53 mm (32-80), volume: 162 mL(60-400)}, 7 ELs were noted {6 II, 1 type I (neck dilata-
tion), no graft migration}.
Conclusions: This is the first report on 1-year FU data
using the Endurant for AAA treatment. The technical
success rate was very high. Stentgraft migration did not
occur and only 1 type Ia EL was seen. The AAA-related
mortality was 1.5%, but the total 1-year mortality was
relatively high. Iliac limb occlusions were seen relatively
frequently, possibly demanding more frequent prophylac-
tic PTA of outflow vessels.
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Objectives: To evaluate the results of a new aortic
endograft for the treatment of abdominal aortic aneurysms
(AAAs) with challenging neck and/or difficult access.
Methods: The definition of a challenging proximal
neck was based on diameter (28 mm), length (15 mm),
angulations (60°), shape (reverse tapered or bulging),
thrombus lining (50%) and tortuosity. The definition of
difficult access was based on the presence of two or more
90° angulations within an iliac artery and concomitant
occlusive disease with external or common iliac artery di-
ameter less than 7mm. Between September 2008 and No-
vember 2009, 46 patients (39 male, mean age 75.82 years)
were treated with the Endurant stent-graft (Medtronic,
Santa Rosa, CA, USA) in our unit. Nine of the 46 patients
(19.56%) had a challenging neck, 13 (28.26%) had hostile
iliac artery anatomy, and 24 (52.18%) had both. The results
were analyzed in terms of technical success, 1-month mor-
tality and morbidity and aorto-iliac complications (en-
doleaks and iliac injuries).
Results: Technical success was achieved in all cases.
Two (4.34%) type-1 endoleaks were detected on comple-
tion angiography (CA) and solved by means of proximal
ballooning. Three (6.52%) type-2 endoleaks detected on
CA were seen to have resolved spontaneously on 1-month
